Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00353574
Status:
TERMINATED
Last Update Posted:
2014-03-18
First Post:
2006-07-17
Brief Title:
DORADO-EX Long-Term Safety Extension Study to the Phase 3 DORADO Study Protocol DAR-311 of Darusentan in Resistant Hypertension
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2010-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-04
Completion Date Type:
ACTUAL
First Submit Date:
2006-07-17
First Submit QC Date:
July 17 2006
Study First Post Date:
2006-07-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2014-01-03
Disp First Submit QC Date:
January 3 2014
Disp First Post Date:
2014-02-04
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-02-19
Last Update Post Date:
2014-03-18
Last Update Post Date Type:
ESTIMATED